Phase: Phase II, Phase IType: Biomarker/Laboratory analysis, TreatmentStatus: CompletedAge: 18 and overSponsor: NCIProtocol IDs: NCI-2012-01442, WSU-C-2679, MAYO-MC0131, NCI-5599, CDR0000331694, MC0131, 5599, N01CM62205, P30CA015083, NCT00070252Phase: Phase II, Phase IType: TreatmentStatus: CompletedAge: 18 and overSponsor: NCIProtocol IDs: NCI-2009-00114, CDR0000409695, 2003-0992, 7004, P30CA016672, N01CM17003, N01CM62202, MDA-2003-0992, NCI-7004, NCT00100750
